Geneva meetings and events:
Global health and related sectors

Sep
5
Tue
Elements for a Treaty on Business and Human Rights
Sep 5 @ 17:00 – 20:00

“In June 2014, the United Nations Human Rights Council established a working group to “elaborate an international legally binding instrument to regulate, in international human rights law, the activities of transnational corporations and other business enterprises”.

This event, taking place at a critical moment to inform the process of elaboration of the draft elements, has been designed to foster the exchange of views among international actors, creating the bases for consensus on possible contents of a legally binding instrument in the field of business and human rights.

Introduction:

  • Andrew Clapham, Professor of International Law, The Graduate Institute
  • Sam Zarifi, Secretary General, International Commission of Jurists
  • Jacqueline Coté, Public Relations Director, The Graduate Institute

Panel I: Prevention, human rights due diligence and disclosure

  • Moderator: Carlos Lopez, Senior Legal Adviser, International Commission of Jurists
  • Douglass Cassel, Professor of Law, University of Notre Dame
  • Makbule Sahan, Acting Legal Director, International Trade Union Confederation
  • Gabriela Quijano, Legal Advisor, Amnesty International

Panel II: Accountability and Remedy

  • Moderator: Marco Sassoli, Professor of International Law, University of Geneva
  • Robert McCoquordale, Director, British Institute of International and Comparative Law

Organised with the International Commission of Jurists.”

……………..
Orgagnizer / source: Graduate Institute

Sep
6
Wed
PIP Framework consultation
Sep 6 – Sep 7 all-day
“Further to the 70th World Health Assembly request to the Director-General in decision WHA70(10)8b (see below), WHO will convene a Consultation with Member States, Advisory Group members, relevant international organizations, GISRS, databases and initiatives, and other interested stakeholders. The Consultation will be held in Geneva on 6-7 November 2017. Please save the date in your calendar. An Agenda and other relevant documents will follow in due course.

WHA70(10)(8)(b): “[T]o request the Director-General, regarding the PIP Framework Review Group’s recommendations concerning seasonal influenza and genetic sequence data, to conduct a thorough and deliberative analysis of the issues raised, including the implications of pursuing or not pursuing possible approaches, relying on the 2016 PIP Framework Review and the expertise of the PIP Advisory Group, and transparent consultation of Member States and relevant stakeholders, including the Global Influenza Surveillance and Response System.”

Questions and comments on the WHA70(10)(8)(b) process can be sent to pipanalysis@who.int
To see the full decision visit http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70(10)-en.pdf

…………………..
Source: PIP Framework newsletter, July 2017
Details not yet available

Oct
9
Mon
English Technical Briefing Seminar on Essential Medicines Policies and Programmes
Oct 9 – Oct 13 all-day

The general English Technical Briefing Seminar includes presentations, briefings and discussions around the following topics:

  • National Medicines Policies and Good Governance
  • Access to Medicines and Country Support Strategies
  • Selection and Rational Use of Essential Medicines
  • Quality Assurance of Medicines and Medical Products
  • Pharmacovigilance
  • Access to Controlled Medicines
  • Medicine Pricing and Financing Strategies
  • Medicine Supply Systems and Procurement
  • Regulatory Systems and Support
  • The WHO Prequalification Programme

Programme English TBS 2017, 09 – 13 October, Geneva – In preparation

There will also be a special “hot topics” session focusing on areas of particular interest and relevance at the time of the seminar.

Participants

The technical briefing seminar will be of interest to Ministry of Health officials who deal with pharmaceutical issues, regional advisers and country office staff of WHO and other UN agencies, national and regional drug regulators, government and non-government officials, academics and pharmaceutical company representatives.

Expected Outcomes

By the end of the seminar participants will:

  • Have a general understanding of the most common problems in the pharmaceutical sector in developing and transitional countries; and will have shared experiences in addressing these challenges;
  • Have a general understanding of how WHO support developing and transitional countries in strengthening the pharmaceutical sector;
  • Be aware of ways to strengthen collaboration with WHO and other organizations supporting the pharmaceutical sector in developing and transitional countries;
  • Be aware of critical issues such as quality and pharmacovigilance, pricing issues, counterfeit medicines.

Seminar design, presenters & facilitators

Each session combines a presentation from a WHO or invited speaker with active discussion and on occasions group work. For each sessions key documents are identified and these together with the PowerPoint slides used are provided to participants after the seminar. One afternoon is available for individual appointments with WHO staff.

Applications

Attendance is limited to 30 places. Participation is free of charge. However, each participant is responsible for own travel and accommodation costs. The closing date for the submission of applications is 31 August 2017. Please apply using the electronic application form in the right column of this page. (Based on past experience we encourage participants from countries for which Schengen visas are required to apply early.)

………………..
Source and registration: WHO website

English Technical Briefing Seminar on Essential Medicines Policies and Programmes (WHO)
Oct 9 – Oct 13 all-day

“The general English Technical Briefing Seminar includes presentations, briefings and discussions around the following topics:

  • National Medicines Policies and Good Governance
  • Access to Medicines and Country Support Strategies
  • Selection and Rational Use of Essential Medicines
  • Quality Assurance of Medicines and Medical Products
  • Pharmacovigilance
  • Access to Controlled Medicines
  • Medicine Pricing and Financing Strategies
  • Medicine Supply Systems and Procurement
  • Regulatory Systems and Support
  • The WHO Prequalification Programme

Programme English TBS 2017, 09 – 13 October, Geneva – In preparation

There will also be a special “hot topics” session focusing on areas of particular interest and relevance at the time of the seminar.

Participants

The technical briefing seminar will be of interest to Ministry of Health officials who deal with pharmaceutical issues, regional advisers and country office staff of WHO and other UN agencies, national and regional drug regulators, government and non-government officials, academics and pharmaceutical company representatives.

Expected Outcomes

By the end of the seminar participants will:

  • Have a general understanding of the most common problems in the pharmaceutical sector in developing and transitional countries; and will have shared experiences in addressing these challenges;
  • Have a general understanding of how WHO support developing and transitional countries in strengthening the pharmaceutical sector;
  • Be aware of ways to strengthen collaboration with WHO and other organizations supporting the pharmaceutical sector in developing and transitional countries;
  • Be aware of critical issues such as quality and pharmacovigilance, pricing issues, counterfeit medicines.

Seminar design, presenters & facilitators

Each session combines a presentation from a WHO or invited speaker with active discussion and on occasions group work.
For each sessions key documents are identified and these together with the PowerPoint slides used are provided to participants after the seminar.
One afternoon is available for individual appointments with WHO staff.

Applications

Attendance is limited to 30 places. Participation is free of charge. However, each participant is responsible for own travel and accommodation costs. The closing date for the submission of applications is 31 August 2017. Please apply using the electronic application form in the right column of this page. (Based on past experience we encourage participants from countries for which Schengen visas are required to apply early.)”

……………..
Source, registration: WHO EMP

Oct
10
Tue
Politico Health Care Summit 2017
Oct 10 all-day

“Agenda setting: doubling down on access to health care

The Health Care Summit 2017 will gather European and global policymakers, industry leaders and key drivers of change in health care for a program focused on the political health care agenda, highlighting the convergence between developed and developing countries as they double down on efforts to increase access to health care.

Building on the success of the 2016 edition in Geneva, stakeholders will deep-dive into the policy instruments and business models that must co-exist to ensure that innovation and efficiency align with accessibility.”

…………………
Source: Conference website
Organizers
: Politico, Le Temps
Sponsors: Pharma and other health sector industry

Oct
23
Mon
​Open-ended intergovernmental working group on transnational corporations and other business enterprises with respect to human rights, 3rd Session (OHCHR)
Oct 23 – Oct 27 all-day

“At its 26th session, on 26 June 2014, the Human Rights Council adopted resolution 26/9 by which it decided “to establish an open-ended intergovernmental working group on transnational corporations and other business enterprises with respect to human rights, whose mandate shall be to elaborate an international legally binding instrument to regulate, in international human rights law, the activities of transnational corporations and other business enterprises.”

The Human Rights Council also decided that the first two sessions of the open-ended intergovernmental working group “shall be dedicated to conducting constructive deliberations on the content, scope, nature and form of the future international instrument.”

Following its first session, which was held from 6 to 10 July 2015, the open-ended intergovernmental working group presented its report to the Council at its thirty-first session (please see the report A/HRC/31/50).​

The second session took place from 24-28 October 2016 and the open-ended intergovernmental working group will present its report to the Council at its thirty-fourth session in March 2016.

The third session will take place from 23 to 27 October 2017.”

……………..
Source: OHCHR

 

UN Treaty on Transnational Corporations & Human Rights and other Business Enterprises: Week of People’s Mobilization (Dismantle Corporate Power)
Oct 23 – Oct 27 all-day
Nov
13
Mon
World Antibiotic Awareness Week (WHO)
Nov 13 – Nov 19 all-day

“Antibiotic resistance is an increasingly serious threat to global health and human development. It is rising to dangerously high levels in all parts of the world, compromising our ability to treat infectious diseases and putting people everywhere at risk.

World Antibiotic Awareness Week aims to increase awareness of this important issue and to encourage best practices among the public, health workers, farmers, food producers, veterinarians and policy makers to avoid the further emergence and spread of antibiotic resistance.

This year, World Antibiotic Awareness Week will be held from 13 to 19 November.

WHO is encouraging all Member States, health partners and students, and the public to join this campaign and help raise awareness of antibiotic resistance.

It is not too late to reduce the impact of antibiotic resistance and we all have a part to play in preserving the effectiveness of antibiotics.

Antibiotics are a precious resource—we need to handle them with care.”

………………..
Geneva WAAW events: not yet known
Source: WHO

Nov
27
Mon
2017 United Nations Forum on Business and Human Rights
Nov 27 – Nov 29 all-day

“The UN Forum is the world’s largest annual gathering on business and human rights with more than 2,000 participants from government, business, community groups and civil society, law firms, investor organisations, UN bodies, national human rights institutions, trade unions, academia and the media.

The 2017 Forum will have a major focus on the issue of access to remedy for business-related human rights impacts – the third pillar of the UN Guiding Principles on Business and Human Rights. In order to inform preparations, the Forum Secretariat is doing a mapping of ongoing research and projects linked to this topic. All stakeholders are encouraged to submit brief information about ongoing or planned research and projects for 2017-18 related to the issue of access to remedy in the context of business and human rights. The information should be submitted via this online form.”

……………….
Source: OHCHR website

Dec
5
Tue
A 1000 days of SDGs – Looking ahead. Global Meeting of Global Health Policy Think Tanks and Academic Institutions
Dec 5 – Dec 6 all-day

“In the context of the first 1000 days of SDG implementation, it is critical to seize the momentum to strategically analyse implementation approaches and mechanisms. Following the success of the first-ever meeting of global health policy think tanks and academic institutions in November 2015 in Geneva, the international network THINK_SDGs was launched. It capitalises on the analytical capacities and creative thinking of policy research institutions to accelerate implementation of health-related Sustainable Development Goals (SDGs) through knowledge sharing, capacity building and innovation. Several regional hubs work at the regional and national levels to analyse context-relevant implementation challenges and offer best practices for civic engagement and monitoring.

Drawing on these local realities and following the voluntary national reviews taking place at the High-level Political Forum in July 2017, the Global Health Centre at the Graduate Institute will host the Second Global Meeting of Global Health Policy Think Tanks and Academic Institutions on 4-5 December 2017. It will bring together representatives from leading policy analysis institutions from around the world and Geneva-based global health stakeholders to analyse the political determinants of SDG implementation and identify entry points for think tanks to inform and transform policies.

Special attention will be given to governance mechanisms fostering new development models based on co-benefits and co-production; to the creation of political processes at the national and global levels to support implementation and accountability; and to strategies for effective stakeholder engagement. By giving a strong voice to participants from the Global South, the meeting will combine a multitude of perspectives and stimulate innovative thinking beyond the North-South divide, while promoting country ownership in the implementation of health-related SDGs.

Roundtable discussions, working groups and public panels will allow for a high degree of interaction to share experiences and good practices. The promotion of synergies between think tanks and global health actors in Geneva will also facilitate the emergence of new ideas and the establishment of new collaborations. The meeting’s outcomes will be amplified and translated to regional and national contexts through the THINK_SDGs network and its regional hubs.

For more information on THINK_SDGs, please visit ghptt.graduateinstitute.ch”

……………………….
Source: Graduate Institute

Jan
22
Mon
142nd Session of the WHO Executive Board (EB142)
Jan 22 – Jan 27 all-day

“The WHO Executive Board is composed of 34 members technically qualified in the field of health. Members are elected for three-year terms. The main Board meeting, at which the agenda for the forthcoming Health Assembly is agreed upon and resolutions for forwarding to the Health Assembly are adopted, is held in January, with a second shorter meeting in May, immediately after the Health Assembly, for more administrative matters. The main functions of the Board are to give effect to the decisions and policies of the Health Assembly, to advise it and generally to facilitate its work.”

………………..
Source: WHO
EB142: WHO Website
EB142: Draft provisional agenda

Apr
10
Tue
Geneva Health Forum 2018
Apr 10 – Apr 12 all-day

“The Geneva Health Forum (GHF), a biennial event launched in 2006 and held in the Spring, combines plenary and parallel sessions attended by hundreds of participants, with a large international exhibition area.

Geneva University Hospitals (HUG) along with the Faculty of Medicine of the University of Geneva, and Swiss and International organizations committed to Global Health have joined their talents and resources to organize the Geneva Health Forum.

The GHF was established to link policy and practice, and addresses health issues through an integrative approach. It is known as the largest event in Europe gathering such a distinguished audience, composed of academic leaders, practitioners, policy makers, diplomats, representatives of donor agencies and healthcare providers.

Keynotes lectures and plenary sessions are given by international health leaders, and series of workshops, oral and poster sessions are held. These foster and nurture stimulating discussions on major global health issues. All plenary sessions as well as a track of parallel sessions are simultaneously translated in French and English. ghf_4_groupes The GHF also provides a platform for showcasing the international and humanitarian, practice and solution-oriented commitment of the participants, and gives a voice to those active in the frontlines of global health.

Geneva provides a unique opportunity to the leading global health organizations to meet with governmental delegations appointed by most countries through their permanent UN representations. Indeed, Geneva hosts major international organizations in charge of health and humanitarian action, influential foundations, NGOs and public-private partnership organizations in the field of global health.

The Lake Geneva area, often described as the “Health Valley”, presents a unique concentration of healthcare and academic institutions, and is blooming with many innovative biotech, medtech, and engineering start-ups as well as larger companies in the health sector.

The seventh edition of GHF, will take place from April 10-12, 2018 at the International Conference Center of Geneva (CICG).”

……………….
Source: GHF website
Theme 2018: Precision Global Health in the Digital Age
Call for abstracts: http://ghf2018.g2hp.net/call-for-abstracts/